)
Coherus Oncology (CHRS) investor relations material
Coherus Oncology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual Shareholder Meeting scheduled virtually for May 27, 2026, at 1:30 pm PST.
Preliminary proxy filed to announce meeting and proposals; definitive proxy expected April 20, 2026.
Shareholders will receive proxy materials and are encouraged to vote on key proposals.
Voting matters and shareholder proposals
Proposal to reprice employee stock options with strike prices of $5 or more to the closing price on the meeting date.
Proposal requires a majority of votes cast "FOR" to pass.
Additional proposals may be included in the definitive proxy statement.
Board of directors and corporate governance
Directors, executive officers, and certain employees may participate in proxy solicitation.
Information about directors and executive officers, including their interests, is disclosed in the proxy statement.
- Shareholders will vote on director elections, auditor ratification, compensation, and equity plan changes.CHRS
Proxy filing9 Apr 2026 - Rapid oncology pipeline progress and strong LOQTORZI sales drive growth and pivotal trial plans.CHRS
The Citizens Life Sciences Conference 202610 Mar 2026 - LOQTORZI sales doubled, debt slashed, and key oncology trials advance toward 2026 data.CHRS
Q4 20259 Mar 2026 - Strong oncology focus, robust pipeline, and accelerating LOQTORZI sales drive future growth.CHRS
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Q2 revenue hit $65M, UDENYCA surged 60% YoY, divestitures boosted cash, and net loss shrank.CHRS
Q2 20242 Feb 2026 - Accelerating oncology growth with LOQTORZI, UDENYCA, and a robust, partner-driven pipeline.CHRS
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - 2026 will bring pivotal data for innovative oncology assets and drive growth in a $29B market.CHRS
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026 - Q3 revenue hit $70.8M, UDENYCA and LOQTORZI surged, and net loss narrowed sharply.CHRS
Q3 202416 Jan 2026 - UDENYCA sale funds debt reduction and accelerates LOQTORZI's position as NPC standard of care.CHRS
Status Update12 Jan 2026
Next Coherus Oncology earnings date
Next Coherus Oncology earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage